Business Context and Reporting Period
This Form 8-K was filed by Actuant Corporation (not Enerpac Tool Group Corp) on July 8, 2019. The filing reports the entry into a Material Definitive Agreement to sell the Company's Engineered Components & Systems segment (excluding the Cortland U.S. business) to BRWS Parent LLC, an affiliate of One Rock Capital Partners II, LP.
Key Financial Metrics
- Transaction Value: Approximately $214.5 million purchase price (subject to customary adjustments).
- Payment Structure: Approximately $3.0 million to be paid in four quarterly installments post-closing; the remainder is expected at closing.
- Impairment Charge: The Company anticipates recording a non-cash impairment and divestiture charge of approximately $300 million.
- Liquidity/Debt: The filing does not provide specific current liquidity or debt figures, noting only that the transaction is not subject to a financing condition.
Material Changes and Transaction Details
The primary material change is the divestiture of the Engineered Components & Systems segment. The transaction involves the sale of equity interests in newly formed entities holding the business and certain intercompany notes in France and Sweden. The transaction is expected to close in the fourth calendar quarter of 2019, subject to customary closing conditions including antitrust approvals and the absence of a material adverse effect.
Outlook, Risks, and Management Commentary
- Termination Provisions: The agreement includes a termination date of December 31, 2019. The Company is entitled to a termination fee from the Buyer if the agreement is terminated under certain circumstances, guaranteed by an affiliate of the Sponsor.
- Operational Covenants: Between signing and closing, the Company must operate the business in the ordinary course consistent with past practices.
- Risks: The final impairment charge amount may fluctuate based on pre-closing cash flows, foreign exchange rate changes, and working capital amounts. General risks include geopolitical activity, supply chain issues, and competitive pricing.
- Forward-Looking Statements: The Company cautions that actual results may differ from estimates due to various economic and operational factors.
Investor Verification Checklist
- Verify the final closing date, as the transaction is contingent on regulatory approvals and restructuring.
- Monitor the final impairment charge amount, which is currently estimated at $300 million but subject to FX and working capital adjustments.
- Confirm the status of Hart-Scott-Rodino (HSR) waiting periods and other international competition law approvals.
- Review the impact of the $300 million non-cash charge on the Company's upcoming quarterly earnings and balance sheet.
- Check for any updates regarding the termination fee provisions should the deal fail to close by December 31, 2019.